Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6785)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 15, 2022 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abdelhamed W, El-Kassas M. Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event. World J Gastrointest Oncol 2022; 14(6): 1103-1114 [PMID: PMC9244987 DOI: 10.4251/wjgo.v14.i6.1103] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v14/i6/1103.htm |
| Number | Citing Articles |
| 1 |
Jyotsna Gummadi, Xin Wang, Changqing Xie. Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver. Journal of Hepatocellular Carcinoma 2023; : 745 doi: 10.2147/JHC.S406902
|
| 2 |
Mark M Aloysius, Peter Iskander, Khalid Ahmed, Udit Asija, Elmkdad Mohammed, Anthony Iskander, Niraj James Shah, Hemant Goyal, Vikas Khurana, Nasr Simin, Ganesh Aswath, Savio John. Fibrolamellar hepatocellular carcinoma: An epidemiologic and 5-year cancer survival assessment based off SEER data. Clinics and Research in Hepatology and Gastroenterology 2023; 47(7): 102162 doi: 10.1016/j.clinre.2023.102162
|
| 3 |
Eun-A Jeong, Moo-Hyun Lee, An-Na Bae, Jongwan Kim, Jong-Ho Park, Jae-Ho Lee. A Comprehensive Analysis of HOXB13 Expression in Hepatocellular Carcinoma. Medicina 2024; 60(5): 716 doi: 10.3390/medicina60050716
|
| 4 |
Arianna Orsini, Luca Mastracci, Isotta Bozzarelli, Anna Ferrari, Federica Isidori, Roberto Fiocca, Marialuisa Lugaresi, Antonietta D’Errico, Deborah Malvi, Erica Cataldi-Stagetti, Paola Spaggiari, Anna Tomezzoli, Luca Albarello, Ari Ristimäki, Luca Bottiglieri, Kausilia K. Krishnadath, Riccardo Rosati, Uberto Fumagalli Romario, Giovanni De Manzoni, Jari Räsänen, Giovanni Martinelli, Sandro Mattioli, Elena Bonora. Correlations between Molecular Alterations, Histopathological Characteristics, and Poor Prognosis in Esophageal Adenocarcinoma. Cancers 2023; 15(5): 1408 doi: 10.3390/cancers15051408
|
| 5 |
Onyinye Ugonabo, Yochita Pulipati, Adnan Elghezewi, Virginia Miller, Lawrence Logan, Pantangi Pramod. An Unusual Case of Hepatocellular Carcinoma in a Healthy Teenager. Journal of Investigative Medicine High Impact Case Reports 2023; 11 doi: 10.1177/23247096231165744
|
| 6 |
Yolik Ramírez - Marín, Ricardo Cerón Castillo, Miguel Charco Cruz, Gerardo Alejandro Navarro Toledo, Erick Vargas Vélez. Ruptura espontanea de hepatocarcinoma fibrolamelar, abdomen agudo como rara presentación clínica. Presentación de caso. South Florida Journal of Development 2023; 4(4): 1847 doi: 10.46932/sfjdv4n4-030
|
| 7 |
Leonardo G Da Fonseca, Victor Junji Yamamoto, Mateus Trinconi Cunha, Giovanna Sawaya Torre, Raphael Araujo, Gilton Marques Fonseca, Andre Tsin Chih Chen, Aline Chagas, Paulo Herman, Venancio Avancini Ferreira Alves, Flair Jose Carrilho. Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics. Journal of Hepatocellular Carcinoma 2023; : 1923 doi: 10.2147/JHC.S428741
|
| 8 |
Pam Elisabeth van der Meeren, Roeland Frederik de Wilde, Dave Sprengers, Jan Nicolaas Maria IJzermans. Benefit and harm of waiting time in liver transplantation for HCC. Hepatology 2023; doi: 10.1097/HEP.0000000000000668
|
| 9 |
César Gutiérrez Pérez, María Pumares González, Noelia Espinosa Cabria, María Liliana Cabrera Pinos, Laura Calvo Otero, Lina Marcela Valencia Cárdenas, Laura Viña Gopar, Ana María López Muñoz. Fibrolamellar hepatocellular carcinoma treated with chemotherapy and immunotherapy: a rare entity with unique characteristics. Revista Española de Enfermedades Digestivas 2025; doi: 10.17235/reed.2025.11021/2024
|
| 10 |
Ahdab S Bawashkhah, Ghufran A Sindi, Shahad B Almatrafi, Elaf F Obaid, Reda I Bakhsh. Fibrolamellar Hepatocellular Carcinoma in the Absence of Risk Factors: A Case Report. Cureus 2022; doi: 10.7759/cureus.32483
|